Ogkologos

4397 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

FDA Approves Olaparib with Abiraterone and Prednisone (or Prednisolone) for BRCA-mutated...

Ogkologos - 6 Ιουνίου, 2023

Can Cancer Prevention Be Better Integrated into Primary Care?

Ogkologos - 5 Ιουνίου, 2023

Reunión anual de la American Society of Clinical Oncology de 2023:...

Ogkologos - 5 Ιουνίου, 2023

ASCO Annual Meeting 2023: Trastuzumab Deruxtecan Effectively Treats HER2-Expressing Tumors and...

Ogkologos - 5 Ιουνίου, 2023

Clinical and Biological Activity of Patritumab Deruxtecan in Patients with HR-positive,...

Ogkologos - 5 Ιουνίου, 2023

Adding Capivasertib to Fulvestrant Results in Longer PFS in Patients with...

Ogkologos - 5 Ιουνίου, 2023

Reunión anual de la American Society of Clinical Oncology de 2023:...

Ogkologos - 4 Ιουνίου, 2023

ASCO Annual Meeting 2023: Improving Outcomes in Glioma, Hodgkin Lymphoma, Lung...

Ogkologos - 4 Ιουνίου, 2023

Reunión anual de la American Society of Clinical Oncology de 2023:...

Ogkologos - 3 Ιουνίου, 2023

ASCO Annual Meeting 2023: Adding Durvalumab and Olaparib to Treatment Delays...

Ogkologos - 3 Ιουνίου, 2023

1...128129130...440 Σελίδα 129 από 440

MOST POPULAR

Trial Results Highlight Changing Lung Cancer Treatment Landscape

15 Οκτωβρίου, 2018

ESMO Calls for Cardio-Oncology to Be Integrated into the EU Cardiovascular...

17 Σεπτεμβρίου, 2025

Additional 5 Years of AI Treatment Reduces Distant Recurrence Rates Among...

25 Αυγούστου, 2025

Coming together for Zynlonta

2 Ιουλίου, 2021

Φόρτωση περισσοτέρων

FDA Approves Olaparib with Abiraterone and Prednisone (or Prednisolone) for BRCA-mutated...

Can Cancer Prevention Be Better Integrated into Primary Care?

Reunión anual de la American Society of Clinical Oncology de 2023:...

ASCO Annual Meeting 2023: Trastuzumab Deruxtecan Effectively Treats HER2-Expressing Tumors and...

Clinical and Biological Activity of Patritumab Deruxtecan in Patients with HR-positive,...

Adding Capivasertib to Fulvestrant Results in Longer PFS in Patients with...

Reunión anual de la American Society of Clinical Oncology de 2023:...

ASCO Annual Meeting 2023: Improving Outcomes in Glioma, Hodgkin Lymphoma, Lung...

Reunión anual de la American Society of Clinical Oncology de 2023:...

ASCO Annual Meeting 2023: Adding Durvalumab and Olaparib to Treatment Delays...

MOST POPULAR

Trial Results Highlight Changing Lung Cancer Treatment Landscape

ESMO Calls for Cardio-Oncology to Be Integrated into the EU Cardiovascular...

Additional 5 Years of AI Treatment Reduces Distant Recurrence Rates Among...

Coming together for Zynlonta

HOT NEWS

Children’s cancer charities team up for tomorrow’s treatments

Adding Belzutifan to Pembrolizumab Prolongs DFS After Nephrectomy in Patients with...

Groom Uses Wedding To Ask Stepdaughters If He Can Adopt Them

SARS-CoV-2 Antibodies Can Protect from Reinfection, NCI Study Suggests

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ